Search Within

Shanu Modi

  1. "Radiation Oncology, Department of"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
  3. Research Letter (1)
Groups
  1. Breast Medicine Service (7)
  2. Department of Medicine (7)
  3. Radiation Oncology, Department of (7)
  4. Solid Tumor Oncology Division (7)
  5. Biostatistics Service (6)
  6. Epidemiology and Biostatistics (6)

More Groups

People
  1. Simon Powell (5)
  2. Zhigang Zhang (5)
  3. Andrew Seidman (4)
  4. Jonathan Yang (4)
  5. Andreas Rimner (3)
  6. Azadeh Namakydoust (3)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2015 (1)
  6. 2014 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2)
  2. Advances in Radiation Oncology (1)
  3. Annals of Surgical Oncology (1)
  4. Journal of Clinical Oncology (1)
  5. Lancet (1)
  6. npj Breast Cancer (1)
Publishers
  1. Elsevier Inc. (3)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Science, Inc. (1)
  4. Nature Publishing Group (1)
  5. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local therapy for isolated central nervous system progression among patients receiving antibody-drug conjugate therapy
    Research Letter

    Lebow, E. S.; Eichholz, J.; Zhang, Z.; Toumbacaris, N.; Imber, B.; Chen, L.; LaPlant, Q.; Yamada, J.; Pike, L. R. G.; Modi, S.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases
    Journal Article

    Page, D. B.; Beal, K.; Linch, S. N.; Spinelli, K. J.; Rodine, M.; Halpenny, D.; Modi, S.; Patil, S.; Young, R. J.; Kaley, T.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • The effect of molecular subtype and residual disease on locoregional recurrence in breast cancer patients treated with neoadjuvant chemotherapy and postmastectomy radiation
    Journal Article

    Yang, T. J.; Morrow, M.; Modi, S.; Zhang, Z.; Krause, K.; Siu, C.; McCormick, B.; Powell, S. N.; Ho, A. Y.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Does biologic subtype and pathologic response after neoadjuvant chemotherapy predict locoregional recurrence?
    Meeting Abstract

    Yang, T. J.; Morrow, M.; Modi, S.; Krause, K.; Siu, C.; Gupta, G. P.; McCormick, B.; Powell, S. N.; Ho, A. Y.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save